Back to Search Start Over

The Diagnosis of Protein Energy Wasting in Chronic Peritoneal Dialysis Patients Is Influenced by the Method of Calculating Muscle Mass. A Prospective, Multicenter Study.

Authors :
Roth-Stefanski CT
Rodrigues de Almeida N
Biagini G
Scatone NK
Nerbass FB
de Moraes TP
Source :
Frontiers in medicine [Front Med (Lausanne)] 2021 Aug 25; Vol. 8, pp. 702749. Date of Electronic Publication: 2021 Aug 25 (Print Publication: 2021).
Publication Year :
2021

Abstract

Objective: To analyze the concordance and agreement between bioimpedance spectroscopy (BIS) and anthropometry for the diagnosis of protein energy wasting (PEW) in chronic peritoneal dialysis patients. Methods: Prospective, multi-center, observational study using multifrequency bioimpedance device ( Body Composition Monitor -BCM <superscript>®</superscript> - Fresenius Medical Care ) and anthropometry for the diagnosis of PEW as recommended by the International Society of Renal Nutrition and Metabolism (ISRNM). Cohen's kappa was the main test used to analyze concordance and a Bland-Altmann curve was built to evaluate the agreement between both methods. Results: We included 137 patients from three PD clinics. The mean age of the study population was 57.7 ± 14.9, 47.8% had diabetes, and 52.2% were male. We calculated the scores for PEW diagnosis at 3 and 6 months after the first collection (T3 and T6) and on average 40% of the study population were diagnosed with PEW. The concordance in the diagnosis of PEW was only moderate between anthropometry and BIS at both T3 and T6. The main factor responsible for our results was a low to moderate correlation for muscle mass in kilograms, with an r-squared (R2) of 0.35. The agreement was poor, with a difference of more than 10 kg of muscle mass on average and with more than a quarter of all cases beyond the limits of agreements. Conclusion: Current diagnosis of PEW may differ depending on the tools used to measure muscle mass in peritoneal dialysis patients.<br />Competing Interests: TdM is a speaker of AstraZeneca, Bayer, Baxter, Boehringer-Lilly, Siemmens and Takeda; TdM has a research grant from Baxter Brazil. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Roth-Stefanski, Rodrigues de Almeida, Biagini, Scatone, Nerbass and de Moraes.)

Details

Language :
English
ISSN :
2296-858X
Volume :
8
Database :
MEDLINE
Journal :
Frontiers in medicine
Publication Type :
Academic Journal
Accession number :
34513874
Full Text :
https://doi.org/10.3389/fmed.2021.702749